We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.93B
AUM Growth
+$244M
Cap. Flow
+$17M
Cap. Flow %
0.43%
Top 10 Hldgs %
14.31%
Holding
1,432
New
108
Increased
538
Reduced
575
Closed
84

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$7.62M
2
BABA icon
Alibaba
BABA
+$7.25M
3
TDOC icon
Teladoc Health
TDOC
+$4.82M
4
TSN icon
Tyson Foods
TSN
+$4.64M
5
QCOM icon
Qualcomm
QCOM
+$3.85M

Sector Composition

Rank Sector Weight
1 Technology 13.34%
2 Healthcare 12.65%
3 Financials 11.21%
4 Industrials 9.34%
5 Consumer Discretionary 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQI icon
1301
Invesco Quality Municipal Securities
IQI
$528M
$116K ﹤0.01%
10,000
SBBP
1302
DELISTED
Strongbridge Biopharma plc.
SBBP
$116K ﹤0.01%
23,905
+9,152
+62% +$46.8K
WPG
1303
DELISTED
Washington Prime Group Inc.
WPG
$113K ﹤0.01%
1,716
+366
+27% +$25.3K
SAN icon
1304
Banco Santander
SAN
$202B
$111K ﹤0.01%
23,210
-324
-1% -$1.63K
SNAP icon
1305
Snap
SNAP
$7.89B
$110K ﹤0.01%
13,019
-9,434
-42% -$110K
MEN
1306
DELISTED
Blackrock Muni Enhanced Fund, Inc.
MEN
$103K ﹤0.01%
+10,204
New +$106K
ATAXZ
1307
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$99K ﹤0.01%
17,424
-5,846
-25% -$33.2K
VNRX icon
1308
VolitionRx Ltd
VNRX
$9.63M
$96K ﹤0.01%
1,848
RAD
1309
DELISTED
Rite Aid Corporation
RAD
$94K ﹤0.01%
3,700
+40
+1% +$1.23K
EHI
1310
Western Asset Global High Income Fund
EHI
$175M
$92K ﹤0.01%
10,127
-1,055
-9% -$9.67K
ATNM icon
1311
Actinium Pharmaceuticals
ATNM
$26.3M
$87K ﹤0.01%
3,943
+1,491
+61% +$30.4K
ATRS
1312
DELISTED
Antares Pharma, Inc.
ATRS
$86K ﹤0.01%
25,600
AKS
1313
DELISTED
AK Steel Holding Corp
AKS
$84K ﹤0.01%
+17,200
New +$78.6K
STGW icon
1314
Stagwell
STGW
$2.1B
$82K ﹤0.01%
19,740
-14,500
-42% -$70.9K
DSM
1315
BNY Mellon Strategic Municipal Bond Fund
DSM
$288M
$81K ﹤0.01%
+11,000
New +$82.8K
AG icon
1316
First Majestic Silver
AG
$7.73B
$80K ﹤0.01%
14,081
-8
-0.1% -$50
FPI
1317
Farmland Partners
FPI
$411M
$80K ﹤0.01%
12,000
RMTI icon
1318
Rockwell Medical
RMTI
$28M
$70K ﹤0.01%
152
S
1319
DELISTED
Sprint Corporation
S
$67K ﹤0.01%
10,251
-3,630
-26% -$21.6K
LFWD icon
1320
ReWalk Robotics
LFWD
$19.7M
$64K ﹤0.01%
34
+9
+36% +$17.9K
ASXC
1321
DELISTED
Asensus Surgical, Inc.
ASXC
$62K ﹤0.01%
+823
New +$55.7K
ABDC
1322
DELISTED
Alcentra Capital Corp
ABDC
$61K ﹤0.01%
10,198
OPK icon
1323
Opko Health
OPK
$993M
$55K ﹤0.01%
16,014
-1,300
-8% -$6.9K
JCP
1324
DELISTED
J.C. Penney Company, Inc.
JCP
$48K ﹤0.01%
29,400
+5,000
+20% +$10.6K
SCU
1325
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$47K ﹤0.01%
3,200
+1,600
+100% +$30.3K

Similar funds

Oppenheimer & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Oppenheimer & Co held 1,432 positions worth $3.93B, up 6.6% from $3.68B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2018 filing shows 108 new, 538 increased, 575 reduced and 84 closed positions. Its largest new stake was Invesco DB Commodity Index Tracking Fund: 113,354 shares worth $2.04M. The largest sale was A V Homes, Inc., an estimated $12.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q3 2018 buy was Invesco DB Commodity Index Tracking Fund: 113,354 shares worth $2.04M.
  • Oppenheimer & Co added most to Meta Platforms (Facebook) in Q3 2018, an estimated $7.62M increase.
  • Oppenheimer & Co's biggest Q3 2018 reduction was Wabtec, cutting an estimated $4.88M.
  • Oppenheimer & Co fully exited A V Homes, Inc. in Q3 2018, selling an estimated $12.7M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.93B portfolio in Q3 2018.
  • Oppenheimer & Co opened 108 new positions and closed 84 in Q3 2018.
  • Oppenheimer & Co's portfolio value rose 6.6% quarter-over-quarter to $3.93B.

Based on Oppenheimer & Co's 13F filing for Q3 2018, filed 26 Oct 2018.